News
What comes after the breakthrough: How blood-based biomarkers will reshape the Alzheimer’s disease diagnostic pathway
We know that blood-based biomarkers can detect Alzheimer’s disease. But what changes when these tests become a regular part of medical care?
Antibiotic Resistance Prediction and Quality Monitoring
AI, rapid susceptibility testing, and smarter quality monitoring are reshaping antibiotic resistance detection in clinical microbiology labs.
Beer, wine or spirits: A large study finds different mortality patterns for each
Researchers analyzed data from 340,924 participants and found that high total alcohol consumption was associated with greater all-cause, cardiovascular, and cancer mortality, while moderate consumption was linked to increased cancer mortality.
Taking agentic and physical AI from hype to hospital floors
The complete operational roadmap for scaling agentic AI and physical hospital robotics beyond pilots, covering ROI, governance, and adoption strategy.
Innovations in mass spectrometry improve speed and access
Mass spectrometry (MS) is a powerful analytical technique that provides labs with increased sensitivity and specificity compared to standard immunoassays and other forms of chemical analysis. However, clinical lab adoption of MS can be deterred by the labor- and time-intensive demands of this complex analytical technique.
Are antibiotics in travel luggage a gateway to building resistance?
Antibiotics brought into the country by air travellers may be a bigger problem than previously thought.
A $10 chip that could put a medical lab on your wrist
Cambridge researchers have created a ground breaking $10 optical sensor that delivers the precision of laboratory equipment in a device small enough for wearable technology.
Reliable Diagnostics Are the Foundation for Scaling Transplant Programs
As transplant programs scale, robust testing, matching, and monitoring are essential to expanding access while protecting patients on the waiting list.
Emerging arboviral infections and blood safety
Arboviruses represent a growing new challenge for blood safety.
Milestone cancer vaccine success leaves hard questions unanswered
As details emerge of the first tailormade cancer vaccine to prove itself in a major treatment trial, researchers are beginning to ask what the success truly means.